Summit Therapeutics (SMMT) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

SMMT is expected to report earnings to fall 25.78% to -6 cents per share on November 06

Summit Therapeutics SMMT Stock Earnings Reports

Q3'24

Est.

$-0.07

Q2'24

Missed

by $0.03

Q1'24

Beat

by $0.01

Q4'22

Beat

by $0.19

Q3'22

Beat

by $0.12

The last earnings report on August 06 showed earnings per share of -9 cents, missing the estimate of -5 cents. With 5.67M shares outstanding, the current market capitalization sits at 15.35B.

View a ticker or compare two or three

Compare

SMMT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SMMT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for SMMT (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of novel medicines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

601 Brickell Key Drive

Phone

+1 650 460-8308

Employees

105

Web

https://www.smmttx.com